Schizophrenia trials in Portugal
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Guimaraes, Lisbon, Senhora Da Hora, Torres Vedras
- Age
- 55 years to 90 years
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Where
- Guimaraes, Lisbon, Torres Vedras
- Age
- 55 years to 90 years
- People
- 300 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00 - Phase 2Enrolling by invitationAn Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
- Where
- Guimaraes, Lisbon, Torres Vedras
- Age
- 55 years to 91 years
- People
- 210 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT07459660 · EU 2025-521757-16-00 - No phaseTaking peopleMultimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Acting Injectable Antipsychotics
- Where
- Vila Real
- Age
- 18 years and over
- People
- 44
- Run by
- University of Trás-os-Montes and Alto Douro
See details and how to joinNCT07360665 - Phase 1Not yet taking people in PortugalA Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavailability at Steady-State of LY03010 versus XEPLION® in Patients with Schizophrenia
- Where
- Braga, Leiria, Touguinho, Vila Nova de Gaia
- Age
- 18 years and over
- People
- 170 worldwide
- Run by
- Geneora Pharma (Shijiazhuang) Co. Ltd.
See details and how to join2023-508981-13-00 · EU 2023-508981-13-00